Murraya Koenigii Beyond Culinary Use: Advanced Neuroprotective and Anti-Parkinson Potential
International Journal of Drug Delivery Technology · 03.06.2026 · 16 (52s)
DOI: 10.25258/ijddt.16.52s.62 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 03.06.2026. Verfasst von Koyyana Yochanasree und 7 weiteren Autor:innen.
Abstract (Originalsprache)
The curry leaf (Murraya koenigii (L.) Spreng), well-known for its contribution in South Asian cuisine. But, recent studies show it has considerable pharmacological potential in neuroprotection and against neurodegenerative diseases. Background: Parkinson's disease (PD) is a progressive neurodegenerative disease which involves the loss of dopaminergic neurons and accumulation of α-synuclein. The current PD treatments are limited because they only alleviate symptoms and don't slow the disease process.Natural products are becoming more popular due to their low side effects and more concentrated process. M. koenigii is rich in bioactive phytochemicals particularly with carbazole alkaloids like mahanine, girinimbine and koenimbine, which are largely known as high antioxidants with antiinflammatory and anti-apoptotic properties. These compounds impact on important molecular pathways linked to pathobiology of Parkinson's disease (PD) such as oxidative stress, mitochondrial dysfunction and neuroinflammation.Experimental research in in vitro and in vivo neurotoxicity models (rotenone and paraquat) have shown that it is capable of maintaining antioxidant defenses, enhancing behavioral outcomes, and enhancing dopaminergic neuron protection. Furthermore, M. koenigii can inhibit the aggregation of α-synuclein or acetylcholinesterase activity, in most of the cases, it can be prevented by diet. While preclinical studies are encouraging, some obstacles like low bioavailability, variable extracts and insufficient clinical studies must be addressed before it can be translated. This review covers the phytochemistry, the neuroprotective mechanism and the anti-Parkinson potential of M. koenigii, and suggests future research directions on the development of M. koenigii as a novel neurotherapeutic agent.
Zitieren
APA
Yochanasree, K., Raju, K. D., Priya, G. V., Nagalla, K. S. N., Dev, D. R., Vasudhar, R., Yamini, P., & Vasudha, D. (2026). Murraya Koenigii Beyond Culinary Use: Advanced Neuroprotective and Anti-Parkinson Potential. International Journal of Drug Delivery Technology, 16(52s). https://doi.org/10.25258/ijddt.16.52s.62
Vancouver
Yochanasree K, Raju KD, Priya GV, Nagalla KSN, Dev DR, Vasudhar R, et al. Murraya Koenigii Beyond Culinary Use: Advanced Neuroprotective and Anti-Parkinson Potential. International Journal of Drug Delivery Technology. 2026;16(52s). doi:10.25258/ijddt.16.52s.62
BibTeX
@article{Yochanasree2026,
author = {Yochanasree, Koyyana and Raju, Kunda Daniel and Priya, Gummadi Veda and Nagalla, K. Surya Neeraja and Dev, Dharmasoth Rama and Vasudhar, R. and Yamini, P. and Vasudha, D.},
title = {Murraya Koenigii Beyond Culinary Use: Advanced Neuroprotective and Anti-Parkinson Potential},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {52s},
doi = {10.25258/ijddt.16.52s.62}
}
EUVIMED